Maxalt

Getting rid of a migraine with Maxalt

Migraine is a chronic disease, the main symptom of which is a severe headache. Very often, it is accompanied by nausea, vomiting, so that the first migraine attack can easily be mistaken for poisoning. A headache and nausea can be accompanied by a fear of light and sound when any external stimulus instantly worsens the state. The main indication for use of Maxalt is a relief of a migraine attack with or without an aura.

Maxalt with its active substance Rizatriptan is a headache pill that narrows the blood vessels around the brain. Maxalt also reduces substances in the body that can lead to a headache, nausea, sensitivity to light and sound, and other migraine symptoms. Maxalt is used to treat migraines. Rizatriptan will help only with a headache that has already begun. This drug will not prevent headaches and will not reduce the number of exacerbations.

Maxalt should not be used to treat headaches due to tension, headache, which leads to loss of the ability to move with one side of the body, or any other headache that is different from a habitual migraine. Use this medication only if your disease is diagnosed by a doctor like a migraine-induced illness.

Main triggers of a migraine

Scientists managed to identify certain triggers, which provoke migraine attacks in some (but not all) patients. Frequent triggers include stress, lack of sleep and regime change, caffeine, hunger and related hypoglycemia, and mild dehydration. Physical stress can both prevent and provoke a migraine. Certain products can be triggers as well, for example, chocolate, cheese, and red wine. Unfortunately, modern science does not know much about migraines and recommending to all patients the rejection of the same products is inexpedient. The diary can help in determining personal triggers (if they exist).

When the use of Maxalt is contraindicated:

  • hypersensitivity to Rizatriptan – established ischemic heart disease, including myocardial infarction, angina pectoris, documented asymptomatic IHD;
  • decompensated hypertension;
  • Prinzmetal angina;
  • suspected ischemic heart disease;
  • simultaneous therapy or a period of fewer than 2 weeks after the end of treatment with MAO inhibitors.

Patients with a basilar or hemiplegic migraine, with a headache unusual for migraine headaches should not use Maxalt. This drug is also contraindicated in the case of pregnancy, lactation, and children’s age.

Before starting treatment with the drug, a study of the state of the cardiovascular system should be conducted for the patients with a risk of developing IHD (including with AH, diabetes, smoking, the presence of a family history of severe IHD). An interval of at least 6 hours should be between the doses of Rizatriptan and ergotamine preparations.

Dosage guide

Usual adult dose for migraines: Initial dose: 5 mg or 10 mg orally, once a day. If there was a reaction to the first dose, the second dose can be taken at least 2 hours later if migraines returned.

Maximum dose: 30 mg per day

Specialist’s comments:

-10 mg dose may provide a greater effect but there is a greater risk of an adverse reaction.
-This drug should not be used to treat basilar or hemiplegic migraines because such patients are at a greater risk of apoplectic stroke.
– On average, the safety of treating four or more migraine attacks for 30 days is not established by scientists; the efficacy of the second dose or subsequent doses is not established in controlled clinical trials with a result check in the placebo group.
Usual infant formula for migraines:
Children from 6 years and older and weighing less than 40 kg:

– Initial dose: 5 mg orally once a day
Children from 6 years and older and weighing 40 kg or more:

– Initial dose: 10 mg orally once a day
Maximum dose: 1 dose in 24 hours.

Specialist’s comments:

-This drug should not be used to treat basilar or hemiplegic migraines because such patients are at a greater risk of apoplectic stroke.

– On average, the safety of treating four or more migraine attacks for 30 days is not established by scientists; safety and effectiveness of more than one dose during the day was not reliably established.